Forex Signals Dec 23: Canada, US GDP, and BHP, Korea Electric Power Earnings Preview

Today’s  US and Canadian GDP data as well as BHP, Korea Electric Power, and Hyperliquid Strategies earnings highlight a mix of global heavyweights and niche players. Continue reading “Forex Signals Dec 23: Canada, US GDP, and BHP, Korea Electric Power Earnings Preview”

Jannie Mouton Foundation Deal Sparks Bullish Breakout in Curro Share Price, Eyes R15–R20

Curro shares surge as the Jannie Mouton Foundation’s takeover offer clears all conditions, sparking renewed optimism and a potential bullish reversal after years of sideways trading. Continue reading “Jannie Mouton Foundation Deal Sparks Bullish Breakout in Curro Share Price, Eyes R15–R20”

US Stocks Climb with Dow Jones Eyeing 50,000 Amid Strong Tech Performance

As markets manage holiday-season liquidity and get ready for possible short-term gains, US equities rose on Monday thanks to tech leadership, strong earnings, and optimistic investor sentiment.
Continue reading “US Stocks Climb with Dow Jones Eyeing 50,000 Amid Strong Tech Performance”

MU Stock Targeting $300 as Micron Earnings and HBM Demand Calm Valuation Fears

After excellent profits and AI-driven memory demand eliminated pre-results selling pressure and sent shares to new record highs, Micron Technology has reiterated its optimistic narrative.
Continue reading “MU Stock Targeting $300 as Micron Earnings and HBM Demand Calm Valuation Fears”

Intel Stock Comeback Narrative Tested After Nvidia Deal While the Support Holds

After a dramatic comeback from significant losses faded into another decline, Intel has reappeared as a focal point for investors, reigniting discussion over whether its most recent recovery will last.
Continue reading “Intel Stock Comeback Narrative Tested After Nvidia Deal While the Support Holds”

Regencell Bioscience Comeback: RGC Stock in Focus After 100% December Rally

Regencell Bioscience is once again commanding attention after a sharp rebound, reinforcing its reputation as one of the most volatile and speculative biotech stocks in the U.S. market. Continue reading “Regencell Bioscience Comeback: RGC Stock in Focus After 100% December Rally”

Tesla Stock TSLA Bound to Break $500 on Driverless Wins and A Court Ruling

Investor confidence is being rekindled by Tesla’s push toward completely autonomous driving, which is boosting TSLA shares back to all-time highs and bolstering the company’s story of software-led growth.
Continue reading “Tesla Stock TSLA Bound to Break $500 on Driverless Wins and A Court Ruling”

Nike (NKE) Tumbles 11% to $59 as China Weakness Overshadows Earnings Beat

Nike (NKE) shares fell about 11%, closing at $58.71, the lowest level in seven months, following the release of its fiscal Q2 2026 earnings (quarter ended November 30, 2025).

Investors focused on the company’s ongoing challenges in Greater China and margin compression from higher tariffs, despite the company exceeding Wall Street expectations for revenue and earnings.

Nike Delivers Hope and EPS Beat—Investors React with After-Hours Surge

Highlights. Revenue: $12.43 billion, surpassing projections of approximately $12.22 billion and increasing 1% year over year. Diluted EPS: $0.53 (lower than last year due to reduced net income, but better than estimates of around $0.38). Net income: 32% lower than the previous year.

Tariffs, promotions, and inventory cleanup caused a 300-basis-point drop in gross margin to 40.6%. Regional distribution: North America: +9% (strong wholesale growth of about 20–24%). Persistent China Weakness: China, once a major growth engine, continues to lag due to low consumer confidence, fierce competition from regional brands (e.g., The g., Anta, Li-Ning), and excessive reliance on monobrand stores. According to CEO Elliott Hill, the region requires a “reset,” and progress has been slower than expected.

The estimated cost of new US tariffs is $1.5 billion, adding further pressure on margins. Cautious Guidance: Gross margins are projected to decline by 175–225 basis points, and Q3 revenue is expected to decrease by low single digits (worse than expected growth). Under CEO Elliott Hill’s “Win Now” strategy, which focuses on wholesale partnerships and product innovation (e.g., Nike is undergoing a multi-year turnaround.

 

$100 Million Lifeline Sparks Rally for APLD Stock, But Is It Enough to Revive the Uptrend?

Applied Digital’s sharp reversal following a bruising selloff highlights both the resilience and the fragility of investor confidence in the fast-expanding AI infrastructure sector. Continue reading “$100 Million Lifeline Sparks Rally for APLD Stock, But Is It Enough to Revive the Uptrend?”